欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規格
Recombinant Schizosaccharomyces pombe Uncharacterized membrane protein C61.05 (SPCC61.05), partial CSB-YP529656SXV1
CSB-EP529656SXV1
CSB-BP529656SXV1
CSB-MP529656SXV1
CSB-EP529656SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Transcriptional regulatory protein rxt2 (rtx2) CSB-YP529657SXV
CSB-EP529657SXV
CSB-BP529657SXV
CSB-MP529657SXV
CSB-EP529657SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Maintenance of ploidy protein mob1 (mob1) CSB-YP529658SXV
CSB-EP529658SXV
CSB-BP529658SXV
CSB-MP529658SXV
CSB-EP529658SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C1604.06c (SPBC1604.06c), partial CSB-YP529659SXV1
CSB-EP529659SXV1
CSB-BP529659SXV1
CSB-MP529659SXV1
CSB-EP529659SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe GPI transamidase component PIG-T homolog (SPBC1604.15), partial CSB-YP529660SXV
CSB-EP529660SXV
CSB-BP529660SXV
CSB-MP529660SXV
CSB-EP529660SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Probable nucleoporin POM152-like (SPBC29A10.07), partial CSB-YP529661SXV
CSB-EP529661SXV
CSB-BP529661SXV
CSB-MP529661SXV
CSB-EP529661SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Coiled-coil domain-containing protein 124 homolog (SPBC29A10.12) CSB-YP529662SXV
CSB-EP529662SXV
CSB-BP529662SXV
CSB-MP529662SXV
CSB-EP529662SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Probable 26S proteasome regulatory subunit p27 (nas2) CSB-YP529663SXV
CSB-EP529663SXV
CSB-BP529663SXV
CSB-MP529663SXV
CSB-EP529663SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe 54S ribosomal protein L17, mitochondrial (mrpl17) CSB-YP529664SXV
CSB-EP529664SXV
CSB-BP529664SXV
CSB-MP529664SXV
CSB-EP529664SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe L-type lectin-like domain-containing protein C126.08c (SPCC126.08c), partial CSB-YP529665SXV
CSB-EP529665SXV
CSB-BP529665SXV
CSB-MP529665SXV
CSB-EP529665SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Transcription initiation factor IIF subunit alpha (tfg1), partial CSB-YP529666SXV
CSB-EP529666SXV
CSB-BP529666SXV
CSB-MP529666SXV
CSB-EP529666SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Putative GTPase-activating protein C1620.12c (SPCC1620.12c), partial CSB-YP529667SXV
CSB-EP529667SXV
CSB-BP529667SXV
CSB-MP529667SXV
CSB-EP529667SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Meiotically up-regulated gene 167 protein (mug167) CSB-YP529668SXV
CSB-EP529668SXV
CSB-BP529668SXV
CSB-MP529668SXV
CSB-EP529668SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized aminotransferase C660.12c (SPBC660.12c) CSB-YP529669SXV
CSB-EP529669SXV
CSB-BP529669SXV
CSB-MP529669SXV
CSB-EP529669SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Transcription initiation factor TFIID subunit 14 (tfg3) CSB-YP529670SXV
CSB-EP529670SXV
CSB-BP529670SXV
CSB-MP529670SXV
CSB-EP529670SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe FAS1 domain-containing protein C22H12.05c (SPAC22H12.05c), partial CSB-YP529671SXV
CSB-EP529671SXV
CSB-BP529671SXV
CSB-MP529671SXV
CSB-EP529671SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized exonuclease C637.09 (SPAC637.09), partial CSB-YP529672SXV
CSB-EP529672SXV
CSB-BP529672SXV
CSB-MP529672SXV
CSB-EP529672SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe UPF0616 protein C1687.04 (SPAC1687.04), partial CSB-YP529673SXV
CSB-EP529673SXV
CSB-BP529673SXV
CSB-MP529673SXV
CSB-EP529673SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Probable C-5 sterol desaturase 1 (SPAC1687.16c), partial CSB-YP529674SXV1
CSB-EP529674SXV1
CSB-BP529674SXV1
CSB-MP529674SXV1
CSB-EP529674SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe mRNA-binding protein puf3 (puf3), partial CSB-YP529675SXV
CSB-EP529675SXV
CSB-BP529675SXV
CSB-MP529675SXV
CSB-EP529675SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業產品。重組蛋白的技術資源在重組蛋白的開發過程中,除了表達系統之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據他們開發重組蛋白的經驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經過多年的發展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×